The Melanoma Unit has participated in a number of important clinical trials in recent years including:

• MSLT-1 Sentinel Node Biopsy trial
• MSLT-2 Sentinel Node Biopsy trial
• Cancervax, Immunotherapy vaccine trial
• Intergroup adjuvant radiotherapy trial for resected Stage IIIB/C melanoma
• ECOG 1697 Interferon trial
• Ludwig NY-ESO-1 vaccine trial
• BRIM-3 BRAF inhibitor trial
• COMBI-AD
• Checkmate